HHS axes $776 million Moderna bird flu vaccine deal over safety, ethical concerns – NaturalNews.com

• HHS abruptly canceled over $700 million in federal funding for Moderna’s experimental mRNA bird flu vaccine, citing unresolved scientific and ethical concerns – a reversal of the Biden administration’s earlier support.
• HHS criticized mRNA technology as inadequately tested, referencing past Wuhan coronavirus (COVID-19) vaccine controversies (e.g., myocarditis risks) and the lack of long-term safety data for the H5N1 vaccine.
• Moderna defended its Phase 1/2 trial results, claiming strong immune responses and safety. But the funding loss – including a $590M award and $176M BARDA grant – threatens its pandemic-preparedness strategy.
• Officials like HHS Secretary Robert F. Kennedy Jr. raised concerns about “leaky” vaccines accelerating viral mutations.
• HHS plans to prioritize non-mRNA vaccines, reflecting post-COVID skepticism of rapid emergency-use technologies. The move highlights tensions between caution and preparedness amid H5N1’s spread in poultry, livestock and sporadic human cases.

The Department of Health and Human Services (HHS) has abruptly terminated more than $700 million in federal funding for Moderna’s experimental mRNA-based bird flu vaccine, citing unresolved scientific and ethical concerns.

The decision confirmed by HHS Communications Director Andrew Nixon on Thursday, May 29, marks a dramatic reversal from the Biden administration’s earlier support for the project. The canceled funding targeted Moderna’s H5N1 avian influenza vaccine, which relies on the same mRNA platform as its Wuhan coronavirus (COVID-19) injections. The Massachusetts-based vaccine maker’s earlier shot has linked to serious side effects, including myocarditis or heart muscle inflammation.

Officials argue that mRNA technology remains inadequately tested and that taxpayer dollars should not fund a repeat of pandemic-era controversies, where safety warnings were allegedly suppressed. Moderna, however, insists its early trial data shows promise. Nevertheless, the funding cut leaves the future of its H5N1 vaccine in limbo.

Moderna CEO Stephane Bancel vowed to seek alternative funding, but the loss of federal backing deals a blow to the company’s pandemic-preparedness strategy. The rescinded funds include a $590 million award slated for 2025 and a $176 million Biomedical Advanced Research and Development Authority (BARDA) grant from 2024.

A Senate investigation previously revealed that federal health officials debated imposing post-vaccination activity restrictions due to these risks but never acted. Now, HHS claims further investment in mRNA for bird flu is unjustifiable without more rigorous long-term safety data. (Related: SCARE TACTICS: U.S. government gives Moderna $176 million to develop mRNA bird flu vaccine for next fake scamdemic.)

Is this the end of mRNA vaccine technology?

Critics, including some public health experts, argue that abandoning mRNA vaccine technology leaves the U.S. vulnerable if H5N1 mutates into a human pandemic strain. Supporters meanwhile applaud HHS for prioritizing traditional vaccine methods.

Health Secretary Robert F. Kennedy Jr., a vocal skeptic of mass avian vaccinations, has warned that imperfect “leaky” vaccines could accelerate viral mutations in livestock. Agriculture Secretary Brooke Rollins shares her colleague’s concern.

The H5N1 virus has already devastated U.S. poultry, infecting over 173 million birds since 2022. While international protocols typically mandate culling infected flocks, Kennedy and Rollins have pushed for alternative strategies to minimize agricultural disruptions.

According to a statement by Nixon, the move to scrap funding for Moderna’s bird flu shot “signals a shift in federal vaccine funding priorities toward platforms with better-established safety profiles and transparent data practices.” HHS now plans to redirect funds toward non-mRNA vaccines, including next-generation universal flu shots. Ultimately, the move by the health department signals a broader skepticism of emergency-use technologies post-COVID-19, where mandates and rushed approvals fueled public distrust.

Visit BigPharmaNews.com for more similar stories.

Watch Jefferey Jaxen and Del Bigtree tackling the issues and contradictions between the bird flu shot an that of COVID-19 in this clip.

This video is from the Sanivan channel on Brighteon.com.

More related stories:

RFK Jr. exposes the hidden dangers of bird flu vaccines in poultry.

BIRD FLU SCAM: Neither CANADA nor MEXICO have killed a single chicken due to Bird Flu because mysteriously Bird Flu DOES NOT CROSS BORDERS.

Poultry producers worry about proposed bird flu vaccine; jab could SPREAD more bird flu across America!

Deborah Birx’s bird flu fearmongering campaign.

Bird flu hysteria: Another government-backed fear campaign?

Sources include:

YourNews.com

Reuters.com

NPR.org

Brighteon.com